Identity and form
Policosanol is a mixture of long-chain aliphatic alcohols from sugar-cane wax or other sources; composition varies by source.
The label should identify the source, form, preparation, and active or marker amount when those details determine comparability.
What the evidence can answer
Human research has examined Policosanol in relation to cardiovascular physiology. The amount, source, preparation, population, comparator, and measured outcome determine whether a result applies to a finished product.
Current WQ evidence label: Limited human evidence. This label describes the present evidence context, not a promise of benefit.
Safety and decision context
Use-context caution. Combination with anticoagulant or antiplatelet therapy requires professional review.
Review medicines, pregnancy or breastfeeding, allergies, medical history, and the complete finished label with a qualified professional when relevant.
How WQ connects this entry
WQ links this canonical identity to exact aliases, research topics, related ingredient forms, products with matching structured data, and articles that name the same entity. Related does not mean equivalent or recommended.
